As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent. Factors like genetics, autoimmune responses, and environmental toxins ...

Ontario woman seizure-free after getting pioneering skull implant Posted: March 8, 2025 | Last updated: March 8, 2025 An Ontario woman with epilepsy is living seizure-free... after a device was ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving one of the first rare treatments of its kind in Canada — a neurostimulation device ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving one of the first rare treatments of its kind in Canada — a neurostimulation device ...

Brain Implants Market Size, Share & COVID-19 Impact Analysis, By Product (Deep Brain Stimulation, Vagus Nerve Stimulation, and Responsive Neurostimulation), By Application (Epilepsy, Parkinson’s ...

One of those treatments includes outpatient surgery. Inspire implant is a therapy that corrects a person’s obstructive sleep apnea through a remote control. “We kind of refer to it as the ...

Synergia is pursuing its first indication to treat drug-resistant epilepsy (DRE) via vagus nerve stimulation (VNS). Three months post-implantation, results confirm strong safety, robust device ...

The bill could also provide funding for life-saving treatments, such as vagus nerve stimulators, to help reduce the risk of SUDEP for those living with epilepsy. "Dylan passed away in 2017 from ...

To our knowledge, the present study is one of the few prospective ones with a long (5-year for three patients) follow-up of patients who underwent VNS implant for TRD. Findings from our case ...

Brain Implants Market Size, Share & COVID-19 Impact Analysis, By Product (Deep Brain Stimulation, Vagus Nerve Stimulation, and Responsive Neurostimulation), By Application (Epilepsy, Parkinson’s ...

The response rate was 66.7% for focal seizures and 47.4% for ... clinical trial called CORE-VNS. The multicenter, prospective study collected data on seizure outcomes as well as patient-reported ...